The Use of Plasma-Derived Complement C1-Esterase Inhibitor Concentrate (Berinert®) in the Treatment of Angiotensin Converting Enzyme-Inhibitor Related Angioedema

<div>Some scientists hypothesize that patients might be predisposed to develop angioedema due to DNA mutations in the genes encoding the enzymes of the bradykinin pathway [<a href="/journals/criem/2016/3930923/#B20">5</a>–<a href="/journals/criem/2016/3930923/#B26">10</a>].</div>

Case Reports in Emergency Medicine

fig1

Figure 1

Figure 1: The Use of Plasma-Derived Complement C1-Esterase Inhibitor Concentrate (Berinert®) in the Treatment of Angiotensin Converting Enzyme-Inhibitor Related Angioedema 

Figure 1 | The Use of Plasma-Derived Complement C1-Esterase Inhibitor Concentrate (Berinert®) in the Treatment of Angiotensin Converting Enzyme-Inhibitor Related Angioedema 